Ozempic-Maker Invests in Renewables

Novo Holdings, a shareholder with a 77% stake in weight-loss wonderdrug-maker Novo Nordisk, is investing $290 million in renewable energy as stocks in green energy companies take a dip, Bloomberg reported. As Europe’s newly-minted most-valuable company, Novo Nordisk is probably feeling it can afford a roll of the dice.